TCRX — TSCAN THERAPEUTICS INC

Ownership history in XTX Topco Ltd  ·  3 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in TSCAN THERAPEUTICS INC (TCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q3)
Avg. % of fund
0.01%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 219,001 +201,375 +1142.5% 0.01% $219K $1.00
2025 Q3 REDUCED 17,626 -4,812 -21.4% 0.00% $32K $1.82
2024 Q3 INITIATED 22,438 — — 0.01% $112K $4.98
% of Fund (quarterly)    TCRX price (monthly, adj. close)

Other funds also holding TCRX

As of 2025 Q4 — sorted by position size

DC Funds, LP 3Y 43.36% Lynx1 Capital Management LP 3Y 1.62% BVF INC/IL 3Y 7Y 0.18% Deer Management Co. LLC 3Y 0.12% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.02% BAKER BROS. ADVISORS LP 3Y 7Y 0.02% DC Investments Management, LLC 3Y 7Y 0.02% Aberdeen Group plc 3Y 7Y 0.0% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.0%
← Back to XTX Topco Ltd Holdings